Publications

Detailed Information

L-type Ca(2+) channel facilitation mediated by H(2)O(2)-induced activation of CaMKII in rat ventricular myocytes

DC Field Value Language
dc.contributor.authorSong, Young-Hwan-
dc.contributor.authorCho, Hana-
dc.contributor.authorRyu, Shin-Young-
dc.contributor.authorYoon, Jin-Young-
dc.contributor.authorNoh, Chung-Il-
dc.contributor.authorHo, Won-Kyung-
dc.contributor.authorLee, Suk-Ho-
dc.contributor.authorPark, Sun-Hyun-
dc.date.accessioned2012-06-28T01:38:38Z-
dc.date.available2012-06-28T01:38:38Z-
dc.date.issued2010-04-
dc.identifier.citationJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY; Vol.48(4); 773-780ko_KR
dc.identifier.issn0022-2828-
dc.identifier.urihttps://hdl.handle.net/10371/77709-
dc.description.abstractThe Ca(2+)-dependent facilitation (CDF) of L-type Ca(2+) channels, a major mechanism for force-frequency relationship of cardiac contraction, is mediated by Ca(2+)/CaM-dependent kinase II (CaMKII). Recently, CaMKII was shown to be activated by methionine oxidation. We investigated whether oxidation-dependent CaMKII activation is involved in the regulation of L-type Ca(2+) currents (I(Ca.L)) by H(2)O(2) and whether Ca(2+) is required in this process. Using patch clamp, I(Ca,L) was measured in rat ventricular myocytes. H(2)O(2) induced an increase in I(Ca,L) amplitude and slowed inactivation of I(Ca.L). This oxidation-dependent facilitation (ODF) of I(ca), L was abolished by a CaMKII blocker KN-93, but not by its inactive analog KN-92, indicating that CaMKII is involved in ODF. ODF was not affected by replacement of external Ca(2+) with Ba(2+) or presence of EGTA in the internal solutions. However, ODF was abolished by adding BAFTA to the internal solution or by depleting sarcoplasmic reticulum (SR) Ca(2+) stores using caffeine and thapsigargin. Alkaline phosphatase, beta-iminoadenosine 5`-triphosphate (AMP-PNP), an autophosphorylation inhibitor autocamtide-2-related inhibitory peptide (Alp), or a catalytic domain blocker (CaM-KIINtide) did not affect ODF. In conclusion, oxidation-dependent facilitation of L-type Ca(2+) channels is mediated by oxidation-dependent CaMKII activation, in which local Ca(2+) increases induced by SR Ca(2+) release is required.ko_KR
dc.language.isoenko_KR
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDko_KR
dc.subjectReactive oxygen speciesko_KR
dc.subjectCa(2+)/CaM-dependent protein kinase IIko_KR
dc.subjectL-type Ca(2+) channelsko_KR
dc.subjectL-type Ca(2+) channelsko_KR
dc.subjectSarcoplasmic reticulum Ca(2+) releaseko_KR
dc.subjectCa(2+)-dependent facilitation ofko_KR
dc.subjectL-type Ca(2+) channelsko_KR
dc.subjectOxidation-dependent facilitation ofko_KR
dc.titleL-type Ca(2+) channel facilitation mediated by H(2)O(2)-induced activation of CaMKII in rat ventricular myocytesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor송연환-
dc.contributor.AlternativeAuthor조하나-
dc.contributor.AlternativeAuthor류신영-
dc.contributor.AlternativeAuthor윤진영-
dc.contributor.AlternativeAuthor박선현-
dc.contributor.AlternativeAuthor노정일-
dc.contributor.AlternativeAuthor이석호-
dc.contributor.AlternativeAuthor현원경-
dc.identifier.doi10.1016/j.yjmcc.2009.10.020-
dc.citation.journaltitleJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY-
dc.description.citedreferenceXie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475-
dc.description.citedreferenceErickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048-
dc.description.citedreferenceYan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047-
dc.description.citedreferenceJiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105-
dc.description.citedreferenceWang ZY, 2007, BIOCHEM BIOPH RES CO, V359, P685, DOI 10.1016/j.bbrc.2007.05.172-
dc.description.citedreferenceKajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566-
dc.description.citedreferenceGrueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006-
dc.description.citedreferenceLee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200-
dc.description.citedreferenceBrennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200-
dc.description.citedreferenceRosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029-
dc.description.citedreferenceHudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155-
dc.description.citedreferenceGriffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004-
dc.description.citedreferenceGriffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004-
dc.description.citedreferenceWang SQ, 2004, CIRC RES, V94, P1011, DOI 10.1161/01.RES.0000125883.68447.A1-
dc.description.citedreferenceGaitanaki C, 2003, J EXP BIOL, V206, P2759, DOI 10.1242/jeb.00483-
dc.description.citedreferenceDzhura I, 2003, J PHYSIOL-LONDON, V550, P731, DOI 10.1113/jphysiol.2003.043778-
dc.description.citedreferenceHudmon A, 2002, BIOCHEM J, V364, P593-
dc.description.citedreferenceWu YJ, 2001, J PHYSIOL-LONDON, V535, P679-
dc.description.citedreferenceVaradarajan SG, 2001, AM J PHYSIOL-HEART C, V280, pH280-
dc.description.citedreferenceFurstenau M, 2000, J HYPERTENS, V18, P1215-
dc.description.citedreferenceDzhura I, 2000, NAT CELL BIOL, V2, P173-
dc.description.citedreferenceDelgado C, 1999, J MOL CELL CARDIOL, V31, P1783-
dc.description.citedreferenceSuzuki YJ, 1999, J MOL CELL CARDIOL, V31, P345-
dc.description.citedreferenceSatoh H, 1998, CIRC RES, V83, P1192-
dc.description.citedreferenceAnderson ME, 1998, J PHARMACOL EXP THER, V287, P996-
dc.description.citedreferenceVanderVusse GJ, 1997, PROSTAG LEUKOTR ESS, V57, P85-
dc.description.citedreferenceLi L, 1997, J PHYSIOL-LONDON, V501, P17-
dc.description.citedreferenceMiyamae M, 1996, AM J PHYSIOL-HEART C, V271, pH2145-
dc.description.citedreferenceKawasaki H, 1996, MOL MEMBR BIOL, V13, P217-
dc.description.citedreferenceWARD CA, 1995, J MOL CELL CARDIOL, V27, P1089-
dc.description.citedreferenceCHIAMVIMONVAT N, 1995, CIRC RES, V76, P325-
dc.description.citedreferenceMEISSNER A, 1995, AM J PHYSIOL-HEART C, V268, pH100-
dc.description.citedreferenceDUTOIT EF, 1994, J CARDIOVASC PHARM, V24, P678-
dc.description.citedreferenceXIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659-
dc.description.citedreferenceYUAN WL, 1994, AM J PHYSIOL, V267, pH982-
dc.description.citedreferenceTIAHO F, 1994, J PHYSIOL-LONDON, V477, P237-
dc.description.citedreferenceMORARU II, 1994, ANN NY ACAD SCI, V723, P328-
dc.description.citedreferenceDUAN J, 1992, J CARDIOVASC PHARM, V19, P593-
dc.description.citedreferenceBERESEWICZ A, 1991, J MOL CELL CARDIOL, V23, P899-
dc.description.citedreferenceSTEENBERGEN C, 1990, CIRC RES, V66, P135-
dc.description.citedreferenceLOCHNER A, 1987, BIOCHIM BIOPHYS ACTA, V927, P8-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share